PAULA TWYMAN: Open Payments
NPI 1285294744 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 13 payments from 8 companies in 2025. Trend: 2023 $113 · 2024 $0 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $100 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| ABBVIE INC. | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Tris Pharma Inc | 1 | $18 |
| CeQur Corporation | 1 | $16 |
Products named: Rybelsus, QULIPTA, Ozempic, Wegovy, Auvelity, ZEPBOUND, CAPLYTA, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
